DiaMedica Therapeutics (DMAC) Metrics: History & Chart

DiaMedica Therapeutics Inc.(DMAC)

Biotechnology · Minneapolis, MN

$8.31-0.11 (-1.31%)

Delayed quote: Oct 6, 2026, 3:00 PM EDT

About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. operates as a clinical-stage biopharmaceutical entity dedicated to advancing therapeutic solutions for neurological and renal disorders. Its primary drug candidate, DM199, a recombinant human tissue kallikrein-1 protein, is currently undergoing a Phase 2 REDUX trial to assess its efficacy in treating moderate to severe chronic kidney disease linked to Type 1 or Type 2 diabetes. Furthermore, DM199 is being evaluated in Phase 2/3 REMEDY2 trials for acute ischemic stroke patients. In addition to DM199, the company is also developing DM300, which is in its pre-clinical stage for the treatment of various inflammatory conditions. Founded in 2000 and headquartered in Minneapolis, Minnesota, the company was previously known as DiaMedica Inc. before adopting its current name, DiaMedica Therapeutics Inc., in December 2016.

Minneapolis, MN

35 employees

www.diamedica.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Dietrich John Pauls

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+1.20%
30D Total Return	+24.74%
YTD Total Return	+5.78%
1Y Total Return	+19.09%
3Y Total Return	+264.48%
5Y Total Return	+113.75%
10Y Total Return	+113.68%
15Y Total Return	N/A
20Y Total Return	N/A

2026	+5.78%
2025	+46.59%
2024	+91.20%
2023	+79.75%
2022	-57.64%
2021	-63.21%
2020

CAGR TTM	+19.00%
CAGR 3Y	+53.88%
CAGR 5Y	+16.41%
CAGR 10Y	+7.89%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

DMAC Valuation Metrics

DMAC Stock Price Metrics

DMAC Dividend Metrics

DMAC Growth Rate Metrics

DMAC Discounted Cash Flow Metrics

DMAC Returns By Period

DMAC Yearly Returns

DMAC Average Annual Returns By Period (CAGR)

DMAC Revenue Metrics

DMAC PE Ratio Metrics

DMAC PS Ratio Metrics

DMAC PB Ratio Metrics

DMAC Price to Free Cash Flow Ratio Metrics

DMAC Debt to Equity Ratio Metrics

DMAC PEG Ratio Metrics

DMAC FCF Yield

DMAC Earnings Yield

DMAC EBITDA Yield

DMAC OCF Yield

DMAC EV/EBIT Ratio Metrics

DMAC EV/EBITDA Ratio Metrics

DMAC EV/Assets Ratio Metrics

DMAC EV/Sales Ratio Metrics

DMAC Current Ratio Metrics

DMAC Quick Ratio Metrics

DMAC ROIC Metrics

DMAC Return on Assets Metrics

DMAC Return on Equity Metrics

DMAC Net Profit Margin Metrics

DMAC Gross Profit Margin Metrics

DMAC Tax Rate Metrics

PS Ratio	86.25
PS Ratio Avg TTM	70.70
PS Ratio Avg 3Y	75.54
Current VS TTM Avg	+22.00%
Current VS 3Y Avg	+14.17%
Current VS 5Y Avg	+14.17%

PB Ratio	11.84
PB Ratio Avg TTM	8.04
PB Ratio Avg 3Y	5.21
Current VS TTM Avg	+47.33%
Current VS 3Y Avg	+127.18%
Current VS 5Y Avg	+218.25%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.01
Debt/Equity Ratio Avg 3Y	0.01
Current VS TTM Avg	-18.19%
Current VS 3Y Avg	-32.52%
Current VS 5Y Avg	-20.02%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	387.59
Ev/Ebit Ratio Avg TTM	84.81
Ev/Ebit Ratio Avg 3Y	7.96
Current VS TTM Avg	+356.99%
Current VS 3Y Avg	+4770.34%
Current VS 5Y Avg	+5844.33%

Ev/Ebitda Ratio	370.42
Ev/Ebitda Ratio Avg TTM	81.39
Ev/Ebitda Ratio Avg 3Y	7.94
Current VS TTM Avg	+355.13%
Current VS 3Y Avg	+4563.72%
Current VS 5Y Avg	+5372.63%

Ev/Assets Ratio	9.97
Ev/Assets Ratio Avg TTM	7.02
Ev/Assets Ratio Avg 3Y	4.57
Current VS TTM Avg	+42.04%
Current VS 3Y Avg	+118.00%
Current VS 5Y Avg	+202.63%

Ev/Sales Ratio	81.01
Ev/Sales Ratio Avg TTM	57.58
Ev/Sales Ratio Avg 3Y	63.57
Current VS TTM Avg	+40.70%
Current VS 3Y Avg	+27.43%
Current VS 5Y Avg	+27.43%

Current Ratio	6.72
Current Ratio Avg TTM	9.17
Current Ratio Avg 3Y	13.27
Current VS TTM Avg	-26.74%
Current VS 3Y Avg	-49.34%
Current VS 5Y Avg	-59.89%

Quick Ratio	6.72
Quick Ratio Avg TTM	9.17
Quick Ratio Avg 3Y	13.27
Current VS TTM Avg	-26.74%
Current VS 3Y Avg	-49.34%
Current VS 5Y Avg	-59.89%

ROIC	(100.87%)
ROIC Avg 3Y	(62.48%)
ROIC Avg 5Y	(51.96%)
Current VS 3Y Avg	-61.44%
Current VS 5Y Avg	-94.14%
Current VS 10Y Avg	-72.55%

ROA	(83.42%)
ROA Avg TTM	(19.05%)
ROA Avg 3Y	(14.46%)
Current VS TTM Avg	-337.83%
Current VS 3Y Avg	-476.81%
Current VS 5Y Avg	-547.06%

ROE	(97.92%)
ROE Avg TTM	(80.27%)
ROE Avg 3Y	(58.69%)
Current VS TTM Avg	-21.99%
Current VS 3Y Avg	-66.85%
Current VS 5Y Avg	-97.25%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	200.40%
Tax Rate Avg 3Y	135.96%
Tax Rate Avg 5Y	46.00%
Current VS 3Y Avg	+47.40%
Current VS 5Y Avg	+335.65%
Current VS 10Y Avg	+432.37%